Hot Stocks: Dimerix, NRW Holdings, Nova Minerals

Dimerix launches key trial in Japan as recruitment kicks off

Dimerix (ASX:DXB) has kicked off a key trial in Japan (in terms of patient recruitment) seeking to treat inflammatory diseases. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more. The company’s ACTION 3 trial stands for: “Angiotensin II Type 1 Receptor (AT1R) & Chemokine Receptor 2 (CCR2) Targets for Inflammatory Nephrosis.” It’s a Phase 3 trial…

Hot Stocks: Dimerix, NRW Holdings, Nova Minerals

Wall Street edged higher overnight, as Nvidia’s blowout earnings reignited tech optimism. The chipmaker jumped more than 3% after posting US$44bn in quarterly revenue, driven by soaring demand for its new Blackwell AI chips—despite an $8bn hit from China export controls. That helped lift the S&P 500 by 0.4%, the Nasdaq by 0.39%, and the Dow by 117 points. But political uncertainty loomed, after a US trade court struck down Trump’s sweeping tarif…